Clinical Characteristics of Offspring Born to Parents with Type 2 Diabetes Diagnosed in Youth: Observations from TODAY.
Jeanie B TryggestadMegan M KelseyKimberly L DrewsShirley ZhouNancy ChangElia EscanameSamuel S GiddingElvira IsganaitisSiripoom McKayRachana ShahMichelle Van Namenull nullPublished in: Children (Basel, Switzerland) (2024)
Diabetes exposure during pregnancy affects health outcomes in offspring; however, little is known about in utero exposure to preexisting parental youth-onset type 2 diabetes. Offspring born to participants during the Treatment Options for Type 2 Diabetes in Adolescent and Youth (TODAY) study were administered a questionnaire at the end of the study. Of 457 participants, 37% of women and 18% of men reported 228 offspring, 80% from female participants. TODAY mothers had lower household income (<$25,000) compared to TODAY fathers (69.4% vs. 37.9%, p = 0.0002). At 4.5 years of age (range 0-18 years), 16.7% of offspring were overweight according to the parental report of their primary care provider, with no sex difference. Offspring of TODAY mothers reported more daily medication use compared to TODAY fathers (50/183, 27.7% vs. 6/46, 12.2%, [ p = 0.04]), a marker of overall health. TODAY mothers also reported higher rates of recidivism (13/94) than TODAY fathers (0/23). An Individualized Education Plan was reported in 20/94 (21.3%) offspring of TODAY mothers compared to 2/23 (8.7%) of TODAY fathers. This descriptive study, limited by parental self-reports, indicated offspring of participants in TODAY experience significant socioeconomic disadvantages, which, when combined with in utero diabetes exposure, may increase their risk of health and educational disparities.
Keyphrases
- type diabetes
- high fat diet
- mental health
- primary care
- physical activity
- healthcare
- cardiovascular disease
- young adults
- insulin resistance
- public health
- glycemic control
- adipose tissue
- weight loss
- health information
- emergency department
- pregnant women
- body mass index
- skeletal muscle
- risk assessment
- polycystic ovary syndrome
- preterm birth
- preterm infants
- adverse drug
- health promotion